Found: 115
Select item for more details and to access through your institution.
Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
An antifibrotic compound that ameliorates hyperglycaemia and fat accumulation in cell and HFD mouse models.
- Published in:
- Diabetologia, 2024, v. 67, n. 11, p. 2568, doi. 10.1007/s00125-024-06260-y
- By:
- Publication type:
- Article
SIRT7 suppresses energy expenditure and thermogenesis by regulating brown adipose tissue functions in mice.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-35219-z
- By:
- Publication type:
- Article
Phosphatase protector alpha4 (α4) is involved in adipocyte maintenance and mitochondrial homeostasis through regulation of insulin signaling.
- Published in:
- Nature Communications, 2022, v. 13, p. 1, doi. 10.1038/s41467-022-33842-4
- By:
- Publication type:
- Article
Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B<sub>2</sub> receptor in dog skeletal muscle and rat L6 myoblasts.
- Published in:
- European Journal of Endocrinology, 1998, v. 138, n. 3, p. 344
- By:
- Publication type:
- Article
Baseline Plasma Aldosterone Level and Renin Activity Allowing Omission of Confirmatory Testing in Primary Aldosteronism.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα): Pooled Analysis of Phase 2 and 3 Studies in Dyslipidemic Patients with or without Statin Combination.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 22, p. 5537, doi. 10.3390/ijms20225537
- By:
- Publication type:
- Article
Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 3, p. 706, doi. 10.3390/ijms20030706
- By:
- Publication type:
- Article
Ectopic ACTH-producing neuroendocrine tumor occurring with large recurrent metastatic pheochromocytoma: a case report.
- Published in:
- BMC Endocrine Disorders, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12902-022-01090-8
- By:
- Publication type:
- Article
Mineralocorticoid Receptor May Regulate Glucose Homeostasis through the Induction of Interleukin-6 and Glucagon-Like peptide-1 in Pancreatic Islets.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 5, p. 674, doi. 10.3390/jcm8050674
- By:
- Publication type:
- Article
AMPK and cell proliferation – AMPK as a therapeutic target for atherosclerosis and cancer.
- Published in:
- Journal of Physiology, 2006, v. 574, n. 1, p. 63, doi. 10.1113/jphysiol.2006.108324
- By:
- Publication type:
- Article
Genome-wide linkage analysis of type 2 diabetes mellitus reconfirms the susceptibility locus on 11p13-p12 in Japanese.
- Published in:
- Journal of Human Genetics, 2004, v. 49, n. 11, p. 629, doi. 10.1007/s10038-004-0199-3
- By:
- Publication type:
- Article
Autoimmune Polyglandular Syndrome Type 3 Complicated with IgG4-related Disease.
- Published in:
- Internal Medicine, 2024, v. 63, n. 3, p. 425, doi. 10.2169/internalmedicine.1270-22
- By:
- Publication type:
- Article
Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.
- Published in:
- Nature, 1994, v. 372, n. 6502, p. 186, doi. 10.1038/372186a0
- By:
- Publication type:
- Article
Activation of heat shock response to treat obese subjects with type 2 diabetes: a prospective, frequency-escalating, randomized, open-label, triple-arm trial.
- Published in:
- Scientific Reports, 2016, p. 35690, doi. 10.1038/srep35690
- By:
- Publication type:
- Article
Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A post hoc subgroup analysis of the PIONEER 1, 3, 4 and 8 trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 12, p. 2785, doi. 10.1111/dom.14536
- By:
- Publication type:
- Article
Long‐term (52‐week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT‐2 study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1496, doi. 10.1111/dom.14362
- By:
- Publication type:
- Article
Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52‐week outcomes from the DEPICT‐1 and ‐2 studies.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 549, doi. 10.1111/dom.14248
- By:
- Publication type:
- Article
Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT‐2 study): 52‐week results from a randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1516, doi. 10.1111/dom.14060
- By:
- Publication type:
- Article
Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 540, doi. 10.1111/dom.13922
- By:
- Publication type:
- Article
Superior efficacy with a fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese patients with type 2 diabetes in a phase 3, open‐label, randomized trial
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 12, p. 2674, doi. 10.1111/dom.13856
- By:
- Publication type:
- Article
Superior efficacy with a fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese patients with type 2 diabetes in a phase 3, open‐label, randomized trial
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 12, p. 2674, doi. 10.1111/dom.13856
- By:
- Publication type:
- Article
Efficacy and safety of pemafibrate in people with type 2 diabetes and elevated triglyceride levels: 52‐week data from the PROVIDE study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 7, p. 1737, doi. 10.1111/dom.13686
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of dapagliflozin in combination with insulin in Japanese patients with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 876, doi. 10.1111/dom.13593
- By:
- Publication type:
- Article
Efficacy and safety of dapagliflozin over 1 year as add-on to insulin therapy in Japanese patients with type 2 diabetes: the DAISY (Dapagliflozin Added to patients under InSulin therapY) trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 4, p. 562, doi. 10.1111/dom.12853
- By:
- Publication type:
- Article
The combination of dulaglutide and biguanide reduced bodyweight in Japanese patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 12, p. 1279, doi. 10.1111/dom.12758
- By:
- Publication type:
- Article
The Role of Heat Shock Response in Insulin Resistance and Diabetes.
- Published in:
- Diabetes & Metabolism Journal, 2014, v. 38, n. 2, p. 100, doi. 10.4093/dmj.2014.38.2.100
- By:
- Publication type:
- Article
Impact of COVID‐19 pandemic on behavioral changes and glycemic control and a survey of telemedicine in patients with diabetes: A multicenter retrospective observational study.
- Published in:
- Journal of Diabetes Investigation, 2023, v. 14, n. 8, p. 994, doi. 10.1111/jdi.14027
- By:
- Publication type:
- Article
Updates of incretin‐related drugs for the treatment of type 2 diabetes.
- Published in:
- Journal of Diabetes Investigation, 2023, v. 14, n. 2, p. 189, doi. 10.1111/jdi.13945
- By:
- Publication type:
- Article
Potential of a glucagon‐like peptide‐1 receptor/glucose‐dependent insulinotropic polypeptide receptor/glucagon receptor triagonist for the treatment of obesity and type 2 diabetes.
- Published in:
- Journal of Diabetes Investigation, 2022, v. 13, n. 12, p. 1958, doi. 10.1111/jdi.13896
- By:
- Publication type:
- Article
Efficacy and safety of once‐weekly semaglutide in Japanese individuals with type 2 diabetes in the SUSTAIN 1, 2, 5 and 9 trials: Post‐hoc analysis.
- Published in:
- Journal of Diabetes Investigation, 2022, v. 13, n. 12, p. 1971, doi. 10.1111/jdi.13905
- By:
- Publication type:
- Article
Clinical profiles of hyperglycemic crises: A single‐center retrospective study from Japan.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 8, p. 1359, doi. 10.1111/jdi.13475
- By:
- Publication type:
- Article
Rapid and dramatic glucose‐lowering effect of bromocriptine in an inadequately controlled type 2 diabetes patient with prolactinoma.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 4, p. 668, doi. 10.1111/jdi.13369
- By:
- Publication type:
- Article
Japanese Clinical Practice Guideline for Diabetes 2019.
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 4, p. 1020, doi. 10.1111/jdi.13306
- By:
- Publication type:
- Article
New perspectives on insulin therapy.
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 4, p. 795, doi. 10.1111/jdi.13263
- By:
- Publication type:
- Article
Impacts of the 2016 Kumamoto Earthquake on glycemic control in patients with diabetes.
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 2, p. 521, doi. 10.1111/jdi.12891
- By:
- Publication type:
- Article
Effects of a novel selective peroxisome proliferator‐activated receptor‐α modulator, pemafibrate, on hepatic and peripheral glucose uptake in patients with hypertriglyceridemia and insulin resistance.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 6, p. 1323, doi. 10.1111/jdi.12845
- By:
- Publication type:
- Article
Impacts of tight multifactorial intervention in patients with type 2 diabetes: Implications from the Japan Diabetes Outcome Intervention Trial 3.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 5, p. 1022, doi. 10.1111/jdi.12872
- By:
- Publication type:
- Article
Japanese Clinical Practice Guideline for Diabetes 2016.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 3, p. 657, doi. 10.1111/jdi.12810
- By:
- Publication type:
- Article
Low glucose induces mitochondrial reactive oxygen species via fatty acid oxidation in bovine aortic endothelial cells.
- Published in:
- Journal of Diabetes Investigation, 2017, v. 8, n. 6, p. 750, doi. 10.1111/jdi.12678
- By:
- Publication type:
- Article
Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001-2010: Report of the Committee on Causes of Death in Diabetes Mellitus.
- Published in:
- Journal of Diabetes Investigation, 2017, v. 8, n. 3, p. 397, doi. 10.1111/jdi.12645
- By:
- Publication type:
- Article
New glycemic targets for patients with diabetes from the Japan Diabetes Society.
- Published in:
- Journal of Diabetes Investigation, 2017, v. 8, n. 1, p. 123, doi. 10.1111/jdi.12600
- By:
- Publication type:
- Article
A 1-year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal-bolus insulin therapy (Kumamoto Insulin Degludec Observational study).
- Published in:
- Journal of Diabetes Investigation, 2016, v. 7, n. 5, p. 703, doi. 10.1111/jdi.12496
- By:
- Publication type:
- Article
Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16-week double-blind treatment period.
- Published in:
- Journal of Diabetes Investigation, 2016, v. 7, n. 4, p. 555, doi. 10.1111/jdi.12453
- By:
- Publication type:
- Article
Involvement of advanced glycation end-products in 'hyperglycemic memory'.
- Published in:
- Journal of Diabetes Investigation, 2016, v. 7, n. 3, p. 297, doi. 10.1111/jdi.12405
- By:
- Publication type:
- Article
Mitochondrial reactive oxygen species in the pathogenesis of early diabetic nephropathy.
- Published in:
- Journal of Diabetes Investigation, 2015, v. 6, n. 2, p. 137, doi. 10.1111/jdi.12258
- By:
- Publication type:
- Article
Comparison of the efficacy of sitagliptin and glimepiride dose-up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination.
- Published in:
- Journal of Diabetes Investigation, 2014, v. 5, n. 3, p. 320, doi. 10.1111/jdi.12151
- By:
- Publication type:
- Article
Mild Electrical Stimulation Increases Stress Resistance and Suppresses Fat Accumulation via Activation of LKB1-AMPK Signaling Pathway in C. elegans.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0114690
- By:
- Publication type:
- Article
Mild Electrical Stimulation with Heat Shock Ameliorates Insulin Resistance via Enhanced Insulin Signaling.
- Published in:
- PLoS ONE, 2008, v. 3, n. 12, p. 1, doi. 10.1371/journal.pone.0004068
- By:
- Publication type:
- Article
Atypical Bartter Syndrome with Sensorineural Deafness with G47R Mutation of the β-Subunit for ClC-Ka and ClC-Kb Chloride Channels, Barttin.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 2, p. 781, doi. 10.1210/jc.2002-021398
- By:
- Publication type:
- Article